Opiant Pharmaceuticals to Present at the 2020 Jefferies Virtual Healthcare Conference

SANTA MONICA, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer, Dr. Roger Crystal, will present a company overview at the Jefferies Virtual Healthcare Conference. The presentation will take place on Thursday June 4, 2020, at 2:30 pm EDT. This meeting is being held virtually, and a live webcast of the presentation will be available by visiting the “Investors” section of the company's website: www.opiant.com. A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

For more information visit: www.opiant.com.

Investor Relations Contacts:

Ben Atkins
VP of Corporate Communications and Investor Relations
[e-mail]
[phone]

Dan Ferry
Managing Director
LifeSci Advisors, LLC
[e-mail]
[phone]

Source: Opiant Pharmaceuticals, Inc.